Carla Cabrera Johnson

Carla completed her postdoctoral fellowship at MedImmune/AstraZeneca after receiving her Ph.D. in Tumor Biology at Georgetown University. Her unique background combines experience in drug development and early discovery in pharma with business development, competitive intelligence, and market research in early-stage companies. Carla capitalizes on her industry experience and rigorous scientific training to provide valuable insights to clients.